Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning
Elizabeth F. Krakow(Fred Hutch Cancer Center), Erica E. M. Moodie(McGill University), Michael Hemmer(McGill University), Silvy Lachance(Hôpital Maisonneuve-Rosemont), Mukta Arora(University of Minnesota Medical Center), Stephen R. Spellman(National Marrow Donor Program), Daniel R. Couriel(The University of Texas MD Anderson Cancer Center), Michael Last(McGill University), Tao Wang(Medical College of Wisconsin), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Joseph Pidala(Moffitt Cancer Center), Amin M. Alousi(McGill University)
Cited by 42
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
|Journal of Clinical Oncology|2019|441
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435